Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Francesca Sparano
Observed names:
F. Sparano,
Sparano Francesca,
Sparano, Francesca
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institutions:
Plovdiv University,
University of Campania "Luigi Vanvitelli",
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
ORCID:
0000-0003-3348-6281
Observed ORCID:
0000-0003-3348-6281
OpenAlex ID:
A5016733143
Immunotherapy for head and neck cancer: Present and future
2022
·
Morena Fasano
, Carminia Maria Della Corte
, et al.
·
Critical Reviews in Oncology/Hematology
·
126
PDF
HGF/MET and the Immune System: Relevance for Cancer Immunotherapy
2018
·
Federica Papaccio
, Carminia Maria Della Corte
, et al.
·
International Journal of Molecular Sciences
·
119
PDF
Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy
2021
·
Morena Fasano
, Carminia Maria Della Corte
, et al.
·
Therapeutic Advances in Medical Oncology
·
101
PDF
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC
2019
·
Vincenza Ciaramella
, Ferdinando Carlo Sasso
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
54
PDF
Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer
2020
·
Morena Fasano
, Carminia Maria Della Corte
, et al.
·
ESMO Open
·
50
Ex vivo lung cancer spheroids resemble treatment response of a patient with NSCLC to chemotherapy and immunotherapy: case report and translational study
2019
·
Raimondo Di Liello
, Vincenza Ciaramella
, et al.
·
ESMO Open
·
50
Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers
2020
·
Riccardo Lobefaro
, Giuseppe Viscardi
, et al.
·
Lung Cancer
·
44
CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy
2023
·
Domenico Mallardo
, Mario Fordellone
, et al.
·
Journal of Translational Medicine
·
40
PDF
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab
2023
·
Domenico Mallardo
, Ester Simeone
, et al.
·
Journal of Translational Medicine
·
24
PDF
Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarization
2022
·
Domenico Mallardo
, Ester Simeone
, et al.
·
Journal of Translational Medicine
·
24
PDF
A Combined Proteomic and Transcriptomic Signature Is Predictive of Response to Anti-PD-1 Treatment: A Retrospective Study in Metastatic Melanoma Patients
2024
·
Domenico Mallardo
, Mario Fordellone
, et al.
·
International Journal of Molecular Sciences
·
17
PDF
Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma
2024
·
Domenico Mallardo
, Francesca Sparano
, et al.
·
Cancer Immunology Immunotherapy
·
16
Potential clinical implications of CD4+CD26high T cells for nivolumab treated melanoma patients
2023
·
Domenico Galati
, Serena Zanotta
, et al.
·
Journal of Translational Medicine
·
15
PDF
Sequencing Targeted and Immune Therapy in BRAF-Mutant Melanoma: Lessons Learned
2023
·
Claudia Trojaniello
, Francesca Sparano
, et al.
·
Current Oncology Reports
·
15
PDF
Melanoma neoadjuvant treatment: review and update of recent trials
2025
·
Marco Ferrari
, Bianca Arianna Facchini
, et al.
·
Expert Review of Anticancer Therapy
·
12
PDF
Gene-expression signature predicts autoimmune toxicity in metastatic melanoma
2025
·
Domenico Mallardo
, Mario Fordellone
, et al.
·
Journal for ImmunoTherapy of Cancer
·
10
PDF
PARP inhibitors in testicular germ cell tumors: what we know and what we are looking for
2024
·
Sara Parola
, Christoph Oing
, et al.
·
Frontiers in Genetics
·
10
PDF
Use of liquid biopsy in monitoring therapeutic resistance in EGFR oncogene addicted NSCLC
2020
·
Marialucia Iacovino
, Vincenza Ciaramella
, et al.
·
Exploration of Targeted Anti-tumor Therapy
·
4
PDF
Asymptomatic azygos vein overflow in a young patient with primary mediastinal seminoma
2019
·
Raimondo Di Liello
, Francesca Sparano
, et al.
·
Thoracic Cancer
·
4
PDF
Efficacy and safety of immunotherapy in non-small cell lung cancer patients with poor performance status.
2020
·
Riccardo Lobefaro
, Giuseppe Viscardi
, et al.
·
Journal of Clinical Oncology
·
3
Evaluation of antibody-dependent cell cytotoxicity (ADCC) in lung cancer cell lines treated with combined anti-EGFR and anti-PD-L1 therapy
2019
·
F. Sparano
, G. Barra
, et al.
·
Annals of Oncology
·
2
Efficacy of anti-PD-1 rechallenge in metastatic melanoma: A retrospective analysis.
2025
·
Ester Simeone
, Domenico Mallardo
, et al.
·
Journal of Clinical Oncology
·
1
Prognostic implications of glycemia in non-diabetic patients with metastatic melanoma undergoing immunotherapy.
2025
·
Domenico Mallardo
, Anita Minopoli
, et al.
·
Journal of Clinical Oncology
·
1
Impact of sex on immune-related adverse events in patients with melanoma.
2024
·
Margaret Ottaviano
, Domenico Mallardo
, et al.
·
Journal of Clinical Oncology
·
1
PDF
579 Evaluation of cemiplimab treatment duration: clinical outcomes in advanced CSCC
2023
·
Domenico Mallardo
, Francesca Sparano
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
PDF
Show more works
View as search
Works count:
67
Citation count:
745
H-index:
14
I10-index:
17
Year
Topic
Type